CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Conversion 10% owner acquired 1,827,992 shares (conversion)
- 4 Conversion 10% owner acquired 1,758,158 shares (conversion)
- 4 Open-market buy Director bought 320,000 shares at $14.00 ($4,480,000)
- 4 Conversion 10% owner acquired 1,778,064 shares (conversion)
- 4 Conversion Director acquired 547,353 shares (conversion)
- 4 Open-market buy 10% owner bought 320,000 shares at $14.00 ($4,480,000)
- 4 Conversion Director acquired 1,827,992 shares (conversion)
- 3/A Insider 3/A
- 4 Open-market buy 10% owner bought 50,000 shares at $14.00 ($700,000)
- 4 Conversion 10% owner acquired 13,414 shares (conversion)
- 4 Conversion 10% owner acquired 1,807,820 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 17 · 329 filings